We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.71B
1-Year Est. Return 65.19%
This Fund
S&P 500
This Quarter Est. Return
+14.75%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$3.48B
AUM Growth
+$231M
Cap. Flow
-$87.3M
Cap. Flow %
-2.51%
Top 10 Hldgs %
17.4%
Holding
433
New
64
Increased
81
Reduced
104
Closed
64

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$29M
2
CNC icon
Centene
CNC
+$17.6M
3
KBR icon
KBR
KBR
+$16.5M
4
CDW icon
CDW
CDW
+$16.2M
5
IQV icon
IQVIA
IQV
+$16.1M

Top Sells

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$27M
2
PVH icon
PVH
PVH
+$18.7M
3
TPR icon
Tapestry
TPR
+$18.2M
4
IART icon
Integra LifeSciences
IART
+$18.1M
5
MTZ icon
MasTec
MTZ
+$17.7M

Sector Composition

Rank Sector Weight
1 Healthcare 24.56%
2 Technology 18%
3 Consumer Discretionary 12.44%
4 Industrials 12.24%
5 Energy 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AOS icon
376
A.O. Smith
AOS
$7.78B
-92,225
Closed -$5.46M
ASUR icon
377
Asure Software
ASUR
$245M
-192,205
Closed -$3.07M
CVSA
378
Covista Inc
CVSA
$4.3B
-316,062
Closed -$15.2M
ATI icon
379
ATI
ATI
$25.4B
-380,875
Closed -$9.57M
AXON
380
Axon Enterprise
AXON
$35.9B
-193,356
Closed -$12.2M
BLD
381
DELISTED
TopBuild
BLD
-78,210
Closed -$6.13M
BLMN icon
382
Bloomin' Brands
BLMN
$686M
-530,630
Closed -$10.7M
BWXT icon
383
BWX Technologies
BWXT
$13.4B
-209,660
Closed -$13.1M
CHGG icon
384
Chegg
CHGG
$82.4M
-506,247
Closed -$14.1M
COLL icon
385
Collegium Pharmaceutical
COLL
$711M
-292,878
Closed -$6.99M
DENN
386
DELISTED
Denny's
DENN
-364,210
Closed -$5.8M
EZPW icon
387
Ezcorp Inc
EZPW
$1.86B
-432,890
Closed -$5.22M
GPK icon
388
Graphic Packaging
GPK
$2.86B
-742,925
Closed -$10.8M
HALO icon
389
Halozyme
HALO
$12.1B
-423,305
Closed -$7.14M
IART icon
390
Integra LifeSciences
IART
$1.22B
-281,481
Closed -$18.1M
BRSL
391
Brightstar Lottery PLC
BRSL
$1.93B
-144,405
Closed -$3.36M
KEX icon
392
Kirby Corp
KEX
$7.34B
-127,606
Closed -$10.7M
LRCX icon
393
Lam Research
LRCX
$339B
-5,800
Closed -$100K
MAS icon
394
Masco
MAS
$13.6B
-6,590
Closed -$247K
MED icon
395
Medifast
MED
$134M
-38,751
Closed -$6.21M
MHK icon
396
Mohawk Industries
MHK
$8.74B
-1,180
Closed -$253K
MTZ icon
397
MasTec
MTZ
$17.9B
-348,723
Closed -$17.7M
NTNX icon
398
Nutanix
NTNX
$18.4B
-206,040
Closed -$10.6M
NVMI
399
Nova
NVMI
$10.7B
-24,030
Closed -$655K
NVR icon
400
NVR
NVR
$16.7B
-70
Closed -$208K

Similar funds

Castleark Management's Q3 2018 Portfolio in Review

As of Q3 2018, Castleark Management held 433 positions worth $3.48B, up 7.1% from $3.25B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Castleark Management's Q3 2018 filing shows 64 new, 81 increased, 104 reduced and 64 closed positions. Its largest new stake was Eli Lilly: 289,654 shares worth $31.1M. The largest sale was Charles Schwab, an estimated $27M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Castleark Management's largest Q3 2018 buy was Eli Lilly: 289,654 shares worth $31.1M.
  • Castleark Management added most to CDW in Q3 2018, an estimated $16.2M increase.
  • Castleark Management's biggest Q3 2018 reduction was Charles Schwab, cutting an estimated $27M.
  • Castleark Management fully exited Tapestry in Q3 2018, selling an estimated $18.2M.
  • Castleark Management's ten largest holdings make up 17% of its $3.48B portfolio in Q3 2018.
  • Castleark Management opened 64 new positions and closed 64 in Q3 2018.
  • Castleark Management's portfolio value rose 7.1% quarter-over-quarter to $3.48B.

Based on Castleark Management's 13F filing for Q3 2018, filed 15 Nov 2018.